Statera Biopharma Ownership 2024 | Who Owns Statera Biopharma Now?
Institutional Ownership
0.00%
Institutional Holders
1.00
Statera Biopharma Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ACADIAN ASSET MANAGEMENT LLC | 100.00% | - | 211,836 | -223,026 | -51.29% | 3,000 | Mar 31, 2023 |
TUCKER ASSET MANAGEMENT LLC | 0.70% | - | 1,000 | - | - | 18,000 | Mar 31, 2023 |
IFP ADVISORS, INC | 0.06% | - | 87 | -500 | -85.18% | 271,000 | Mar 31, 2023 |
HRT FINANCIAL LP | - | - | - | -24,494 | -100.00% | - | Mar 31, 2023 |
BELL & BROWN WEALTH ADVISORS, LLC | - | - | - | -17,000 | -100.00% | - | Mar 31, 2023 |
MORGAN STANLEY | - | - | - | -60 | -100.00% | - | Mar 31, 2023 |
UBS GROUP AG | - | - | - | -2,011 | -100.00% | - | Mar 31, 2023 |
ERGOTELES LLC | - | - | - | -28,325 | -100.00% | - | Mar 31, 2023 |
ADVISOR GROUP HOLDINGS, INC. | - | - | - | -30,000 | -100.00% | - | Mar 31, 2023 |
BANK OF AMERICA CORP /DE/ | - | - | - | -100 | -100.00% | - | Mar 31, 2023 |
TWO SIGMA SECURITIES, LLC | - | - | - | -81,303 | -100.00% | - | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | - | - | - | -287 | -100.00% | - | Mar 31, 2023 |
NORTHERN TRUST CORP | - | - | - | -171,110 | -100.00% | - | Mar 31, 2023 |
PRICE T ROWE ASSOCIATES INC /MD/ | - | - | - | -61,200 | -100.00% | - | Mar 31, 2023 |
STATE STREET CORP | - | - | - | -68,247 | -100.00% | - | Mar 31, 2023 |
RENAISSANCE TECHNOLOGIES LLC | - | - | - | -722,390 | -100.00% | - | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -29,967 | -100.00% | - | Mar 31, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -130,774 | -100.00% | - | Mar 31, 2023 |
VANGUARD GROUP INC | - | - | - | -378,677 | -100.00% | - | Mar 31, 2023 |
MILLENNIUM MANAGEMENT LLC | - | - | - | -58,579 | -100.00% | - | Mar 31, 2023 |
Statera Biopharma's largest institutional shareholder is ACADIAN ASSET MANAGEMENT LLC, holding 100.00% of the company's total share outstanding, currently valued at $3.00K. The top 10 institutional shareholders own together 100.76% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ACADIAN ASSET MANAGEMENT LLC | 100.00% | - | 211,836 | -223,026 | -51.29% | 3,000 | Mar 31, 2023 |
IFP ADVISORS, INC | 0.06% | - | 87 | -500 | -85.18% | 271,000 | Mar 31, 2023 |
TUCKER ASSET MANAGEMENT LLC | 0.70% | - | 1,000 | - | - | 18,000 | Mar 31, 2023 |
HRT FINANCIAL LP | - | - | - | -24,494 | -100.00% | - | Mar 31, 2023 |
BELL & BROWN WEALTH ADVISORS, LLC | - | - | - | -17,000 | -100.00% | - | Mar 31, 2023 |
MORGAN STANLEY | - | - | - | -60 | -100.00% | - | Mar 31, 2023 |
UBS GROUP AG | - | - | - | -2,011 | -100.00% | - | Mar 31, 2023 |
ERGOTELES LLC | - | - | - | -28,325 | -100.00% | - | Mar 31, 2023 |
ADVISOR GROUP HOLDINGS, INC. | - | - | - | -30,000 | -100.00% | - | Mar 31, 2023 |
BANK OF AMERICA CORP /DE/ | - | - | - | -100 | -100.00% | - | Mar 31, 2023 |
TWO SIGMA SECURITIES, LLC | - | - | - | -81,303 | -100.00% | - | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | - | - | - | -287 | -100.00% | - | Mar 31, 2023 |
NORTHERN TRUST CORP | - | - | - | -171,110 | -100.00% | - | Mar 31, 2023 |
PRICE T ROWE ASSOCIATES INC /MD/ | - | - | - | -61,200 | -100.00% | - | Mar 31, 2023 |
STATE STREET CORP | - | - | - | -68,247 | -100.00% | - | Mar 31, 2023 |
RENAISSANCE TECHNOLOGIES LLC | - | - | - | -722,390 | -100.00% | - | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -29,967 | -100.00% | - | Mar 31, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -130,774 | -100.00% | - | Mar 31, 2023 |
VANGUARD GROUP INC | - | - | - | -378,677 | -100.00% | - | Mar 31, 2023 |
MILLENNIUM MANAGEMENT LLC | - | - | - | -58,579 | -100.00% | - | Mar 31, 2023 |
The largest Statera Biopharma shareholder by % of total assets is ACADIAN ASSET MANAGEMENT LLC. The company owns 211.84K shares of Statera Biopharma (STAB), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
TUCKER ASSET MANAGEMENT LLC | 0.70% | - | 1,000 | - | - | 18,000 | Mar 31, 2023 |
MORGAN STANLEY | - | - | - | -60 | -100.00% | - | Mar 31, 2023 |
BANK OF AMERICA CORP /DE/ | - | - | - | -100 | -100.00% | - | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | - | - | - | -287 | -100.00% | - | Mar 31, 2023 |
ARCHER INVESTMENT CORP | - | - | - | -300 | -100.00% | - | Mar 31, 2023 |
IFP ADVISORS, INC | 0.06% | - | 87 | -500 | -85.18% | 271,000 | Mar 31, 2023 |
NATIONAL BANK OF CANADA /FI/ | - | - | - | -1,000 | -100.00% | - | Mar 31, 2023 |
UBS GROUP AG | - | - | - | -2,011 | -100.00% | - | Mar 31, 2023 |
UNITED CAPITAL MANAGEMENT OF KS, INC. | - | - | - | -15,000 | -100.00% | - | Mar 31, 2023 |
BELL & BROWN WEALTH ADVISORS, LLC | - | - | - | -17,000 | -100.00% | - | Mar 31, 2023 |
HRT FINANCIAL LP | - | - | - | -24,494 | -100.00% | - | Mar 31, 2023 |
ERGOTELES LLC | - | - | - | -28,325 | -100.00% | - | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -29,967 | -100.00% | - | Mar 31, 2023 |
ADVISOR GROUP HOLDINGS, INC. | - | - | - | -30,000 | -100.00% | - | Mar 31, 2023 |
CI PRIVATE WEALTH, LLC | - | - | - | -43,350 | -100.00% | - | Mar 31, 2023 |
MILLENNIUM MANAGEMENT LLC | - | - | - | -58,579 | -100.00% | - | Mar 31, 2023 |
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | - | - | - | -59,825 | -100.00% | - | Mar 31, 2023 |
PRICE T ROWE ASSOCIATES INC /MD/ | - | - | - | -61,200 | -100.00% | - | Mar 31, 2023 |
STATE STREET CORP | - | - | - | -68,247 | -100.00% | - | Mar 31, 2023 |
TWO SIGMA SECURITIES, LLC | - | - | - | -81,303 | -100.00% | - | Mar 31, 2023 |
As of Mar 31 2023, Statera Biopharma's largest institutional buyer is TUCKER ASSET MANAGEMENT LLC. The company purchased 0.00 stocks of STAB, valued at $18.00K.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
RENAISSANCE TECHNOLOGIES LLC | - | - | - | -722,390 | -100.00% | - | Mar 31, 2023 |
VANGUARD GROUP INC | - | - | - | -378,677 | -100.00% | - | Mar 31, 2023 |
ACADIAN ASSET MANAGEMENT LLC | 100.00% | - | 211,836 | -223,026 | -51.29% | 3,000 | Mar 31, 2023 |
NORTHERN TRUST CORP | - | - | - | -171,110 | -100.00% | - | Mar 31, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -130,774 | -100.00% | - | Mar 31, 2023 |
BLACKROCK INC. | - | - | - | -109,531 | -100.00% | - | Mar 31, 2023 |
TWO SIGMA SECURITIES, LLC | - | - | - | -81,303 | -100.00% | - | Mar 31, 2023 |
STATE STREET CORP | - | - | - | -68,247 | -100.00% | - | Mar 31, 2023 |
PRICE T ROWE ASSOCIATES INC /MD/ | - | - | - | -61,200 | -100.00% | - | Mar 31, 2023 |
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | - | - | - | -59,825 | -100.00% | - | Mar 31, 2023 |
MILLENNIUM MANAGEMENT LLC | - | - | - | -58,579 | -100.00% | - | Mar 31, 2023 |
CI PRIVATE WEALTH, LLC | - | - | - | -43,350 | -100.00% | - | Mar 31, 2023 |
ADVISOR GROUP HOLDINGS, INC. | - | - | - | -30,000 | -100.00% | - | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -29,967 | -100.00% | - | Mar 31, 2023 |
ERGOTELES LLC | - | - | - | -28,325 | -100.00% | - | Mar 31, 2023 |
HRT FINANCIAL LP | - | - | - | -24,494 | -100.00% | - | Mar 31, 2023 |
BELL & BROWN WEALTH ADVISORS, LLC | - | - | - | -17,000 | -100.00% | - | Mar 31, 2023 |
UNITED CAPITAL MANAGEMENT OF KS, INC. | - | - | - | -15,000 | -100.00% | - | Mar 31, 2023 |
UBS GROUP AG | - | - | - | -2,011 | -100.00% | - | Mar 31, 2023 |
NATIONAL BANK OF CANADA /FI/ | - | - | - | -1,000 | -100.00% | - | Mar 31, 2023 |
As of Mar 31 2023, Statera Biopharma's biggest institutional seller is RENAISSANCE TECHNOLOGIES LLC. The company sold -0.72M shares of STAB, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
RENAISSANCE TECHNOLOGIES LLC | - | - | - | -722,390 | -100.00% | - | Mar 31, 2023 |
VANGUARD GROUP INC | - | - | - | -378,677 | -100.00% | - | Mar 31, 2023 |
NORTHERN TRUST CORP | - | - | - | -171,110 | -100.00% | - | Mar 31, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -130,774 | -100.00% | - | Mar 31, 2023 |
BLACKROCK INC. | - | - | - | -109,531 | -100.00% | - | Mar 31, 2023 |
TWO SIGMA SECURITIES, LLC | - | - | - | -81,303 | -100.00% | - | Mar 31, 2023 |
STATE STREET CORP | - | - | - | -68,247 | -100.00% | - | Mar 31, 2023 |
PRICE T ROWE ASSOCIATES INC /MD/ | - | - | - | -61,200 | -100.00% | - | Mar 31, 2023 |
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | - | - | - | -59,825 | -100.00% | - | Mar 31, 2023 |
MILLENNIUM MANAGEMENT LLC | - | - | - | -58,579 | -100.00% | - | Mar 31, 2023 |
CI PRIVATE WEALTH, LLC | - | - | - | -43,350 | -100.00% | - | Mar 31, 2023 |
ADVISOR GROUP HOLDINGS, INC. | - | - | - | -30,000 | -100.00% | - | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -29,967 | -100.00% | - | Mar 31, 2023 |
ERGOTELES LLC | - | - | - | -28,325 | -100.00% | - | Mar 31, 2023 |
HRT FINANCIAL LP | - | - | - | -24,494 | -100.00% | - | Mar 31, 2023 |
BELL & BROWN WEALTH ADVISORS, LLC | - | - | - | -17,000 | -100.00% | - | Mar 31, 2023 |
UNITED CAPITAL MANAGEMENT OF KS, INC. | - | - | - | -15,000 | -100.00% | - | Mar 31, 2023 |
UBS GROUP AG | - | - | - | -2,011 | -100.00% | - | Mar 31, 2023 |
NATIONAL BANK OF CANADA /FI/ | - | - | - | -1,000 | -100.00% | - | Mar 31, 2023 |
ARCHER INVESTMENT CORP | - | - | - | -300 | -100.00% | - | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | - | - | - | -287 | -100.00% | - | Mar 31, 2023 |
BANK OF AMERICA CORP /DE/ | - | - | - | -100 | -100.00% | - | Mar 31, 2023 |
MORGAN STANLEY | - | - | - | -60 | -100.00% | - | Mar 31, 2023 |
Statera Biopharma's largest sold out institutional shareholder by shares sold is RENAISSANCE TECHNOLOGIES LLC, sold -0.72M shares, valued at -, as of undefined.
Statera Biopharma Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 28,249 | - | - | Mar 31, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 378,677 | - | - | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 114,324 | - | - | Feb 29, 2024 |
SCHWAB CAPITAL TRUST | 0.00% | 12,170 | - | - | Feb 29, 2024 |
SUNAMERICA SERIES TRUST | 0.00% | 61,200 | - | - | Mar 31, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 4,234 | - | - | Jan 31, 2024 |
iSHARES TRUST | 0.00% | 108,153 | - | - | Mar 31, 2024 |
EQ ADVISORS TRUST | 0.00% | 4,523 | - | - | Mar 31, 2024 |
Statera Biopharma's largest mutual fund holder by % of total assets is "VANGUARD INSTITUTIONAL INDEX FUNDS", owning 28.25K shares, compromising 0.00% of its total assets.
Statera Biopharma Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
31 Mar, 24 | 1 | - |
31 Dec, 23 | 1 | - |
30 Jun, 23 | 1 | -66.67% |
31 Mar, 23 | 3 | -88.46% |
31 Dec, 22 | 26 | -3.70% |
30 Sep, 22 | 27 | - |
30 Jun, 22 | 27 | 3.85% |
31 Mar, 22 | 26 | - |
31 Dec, 21 | 26 | 18.18% |
30 Sep, 21 | 22 | - |
As of 31 Mar 24, 1 institutions are holding Statera Biopharma's shares, representing an increase of 0.00% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
31 Mar, 24 | 1,000 | - |
31 Dec, 23 | 1,000 | - |
30 Jun, 23 | 1,000 | -99.53% |
31 Mar, 23 | 212,923 | -91.38% |
31 Dec, 22 | 2,470,279 | -16.69% |
30 Sep, 22 | 2,964,994 | -5.97% |
30 Jun, 22 | 3,153,292 | 47.96% |
31 Mar, 22 | 2,131,230 | 4.92% |
31 Dec, 21 | 2,031,198 | 66.72% |
30 Sep, 21 | 1,218,312 | - |
Statera Biopharma (STAB) has 1.00K shares outstanding as of 31 Mar 24, up 0.00% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
31 Mar, 24 | 0.00% | 50000.00% |
31 Dec, 23 | 0.00% | - |
30 Jun, 23 | 0.00% | 1.11% |
31 Mar, 23 | 0.42% | 1.75% |
31 Dec, 22 | 4.92% | 14.11% |
30 Sep, 22 | 5.90% | 14.64% |
30 Jun, 22 | 6.35% | 20.45% |
31 Mar, 22 | 5.57% | 16.65% |
31 Dec, 21 | 5.79% | 28.49% |
30 Sep, 21 | 4.51% | - |
As of 31 Mar 24, Statera Biopharma is held by 0.00% institutional shareholders, representing a 50000.00% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
31 Mar, 24 | - | -100.00% |
31 Dec, 23 | 1 | - |
30 Jun, 23 | - | - |
31 Mar, 23 | - | -100.00% |
31 Dec, 22 | 11 | 83.33% |
30 Sep, 22 | 6 | -40.00% |
30 Jun, 22 | 10 | -41.18% |
31 Mar, 22 | 17 | -15.00% |
31 Dec, 21 | 20 | - |
30 Sep, 21 | 20 | - |
- institutional shareholders have increased their position in STAB stock as of 31 Mar 24 compared to 1 in the previous quarter (a -100.00% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
31 Mar, 24 | - | - |
31 Dec, 23 | - | - |
30 Jun, 23 | - | -100.00% |
31 Mar, 23 | 2 | -71.43% |
31 Dec, 22 | 7 | - |
30 Sep, 22 | 7 | 16.67% |
30 Jun, 22 | 6 | 20.00% |
31 Mar, 22 | 5 | 150.00% |
31 Dec, 21 | 2 | - |
30 Sep, 21 | - | - |
- institutional shareholders have reduced their position in STAB stock as of 31 Mar 24 compared to - in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
31 Mar, 24 | 1 | - | 1,000 | - | 0.00% | 50000.00% | - | -100.00% | - | - |
31 Dec, 23 | 1 | - | 1,000 | - | 0.00% | - | 1 | - | - | - |
30 Jun, 23 | 1 | -66.67% | 1,000 | -99.53% | 0.00% | 1.11% | - | - | - | -100.00% |
31 Mar, 23 | 3 | -88.46% | 212,923 | -91.38% | 0.42% | 1.75% | - | -100.00% | 2 | -71.43% |
31 Dec, 22 | 26 | -3.70% | 2,470,279 | -16.69% | 4.92% | 14.11% | 11 | 83.33% | 7 | - |
30 Sep, 22 | 27 | - | 2,964,994 | -5.97% | 5.90% | 14.64% | 6 | -40.00% | 7 | 16.67% |
30 Jun, 22 | 27 | 3.85% | 3,153,292 | 47.96% | 6.35% | 20.45% | 10 | -41.18% | 6 | 20.00% |
31 Mar, 22 | 26 | - | 2,131,230 | 4.92% | 5.57% | 16.65% | 17 | -15.00% | 5 | 150.00% |
31 Dec, 21 | 26 | 18.18% | 2,031,198 | 66.72% | 5.79% | 28.49% | 20 | - | 2 | - |
30 Sep, 21 | 22 | - | 1,218,312 | - | 4.51% | - | 20 | - | - | - |
Statera Biopharma Insider Shareholders Trades
Open Market Insider Trades
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Open Market Insider Buys
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Insider Sells
All Insider Owners Trades
The last insider sell of Statera Biopharma's stock was made by Miller Langdon L on Jul 23 2021, selling 10,000 shares at $3.00 per share (valued at $30.00K).
Statera Biopharma Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q1 2022 | - | - | - |
Q3 2021 | 10 | 1 | 1000.00% |
Q3 2018 | - | - | - |
Q2 2017 | - | 6 | - |
Q3 2016 | - | 4 | - |
Q2 2016 | - | - | - |
Q3 2015 | - | 2 | - |
Q2 2015 | 10 | - | - |
Q1 2015 | 4 | - | - |
Q4 2014 | - | - | - |
Q3 2014 | 1 | 1 | 100.00% |
Q2 2014 | 10 | 2 | 500.00% |
Q1 2014 | 5 | - | - |
Q2 2013 | 21 | 2 | 1050.00% |
Q1 2013 | 1 | - | - |
Q4 2012 | 2 | 1 | 200.00% |
Q3 2012 | 2 | - | - |
Q2 2012 | 14 | - | - |
Q1 2012 | 8 | 3 | 266.67% |
Q4 2011 | 9 | - | - |
0 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Statera Biopharma's insiders, as of Q1 2022.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q1 2022 | - | - | - |
Q3 2021 | - | - | - |
Q3 2018 | - | - | - |
Q2 2017 | - | - | - |
Q3 2016 | - | - | - |
Q2 2016 | - | - | - |
Q3 2015 | - | - | - |
Q2 2015 | - | - | - |
Q1 2015 | 1 | - | - |
Q4 2014 | - | - | - |
Q3 2014 | - | - | - |
Q2 2014 | - | - | - |
Q1 2014 | - | - | - |
Q2 2013 | 2 | - | - |
Q1 2013 | 1 | - | - |
Q4 2012 | - | - | - |
Q3 2012 | 2 | - | - |
Q2 2012 | 2 | - | - |
Q1 2012 | 4 | 3 | 133.33% |
Q4 2011 | 5 | - | - |
As of Q1 2022, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Statera Biopharma's stocks.
STAB Ownership FAQ
Who Owns Statera Biopharma?
Statera Biopharma is owned by institutional shareholders (0.00%), insiders (0.00%), and public (100.00%). The largest institutional shareholder of Statera Biopharma is ACADIAN ASSET MANAGEMENT LLC (100.00% of total shares) and the top mutual fund owner is VANGUARD INSTITUTIONAL INDEX FUNDS (0.00% of total shares).
Who are the major institutional shareholders of Statera Biopharma?
Statera Biopharma's major institutional shareholders are ACADIAN ASSET MANAGEMENT LLC, TUCKER ASSET MANAGEMENT LLC, IFP ADVISORS, INC, HRT FINANCIAL LP, and BELL & BROWN WEALTH ADVISORS, LLC. The top five shareholders own together 100.76% of the company's share outstanding.
How many Statera Biopharma shareholders are there?
As of Mar 2024, there are 1 institutional shareholders of Statera Biopharma.
What percentage of Statera Biopharma is owned by ACADIAN ASSET MANAGEMENT LLC?
ACADIAN ASSET MANAGEMENT LLC owns 211.84K shares of Statera Biopharma, representing 100.00% of the company's total shares outstanding, valued at $3K (as of Mar 2023).
What percentage of Statera Biopharma is owned by TUCKER ASSET MANAGEMENT LLC?
As of Mar 2023, TUCKER ASSET MANAGEMENT LLC holds 1K shares of Statera Biopharma (STAB), compromising 0.70% of the company, valued at $18K.
What percentage of Statera Biopharma is owned by IFP ADVISORS, INC?
IFP ADVISORS, INC is the third largest holder of Statera Biopharma. The company owns 87 of the company's shares outstanding (worth $271K).